Cerus Endovascular Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $26.4M
Latest Deal Amount
  • Investors
  • 5

Cerus Endovascular General Information

Description

Developer of proprietary interventional neuroradiology devices and delivery systems designed for the treatment of neurovascular diseases. The company's neuroradiology devices and delivery systems are used for the treatment of hemorrhagic strokes and a range of aneurysm morphologies, including unruptured wide-necked bifurcation and bifurcation aneurysms, enabling the interventional neuroradiologists to treat minimally invasive neurovascular diseases, particularly intracranial aneurysms.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 47757 Fremont Boulevard
  • Fremont, CA 94538
  • United States
+1 (510) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cerus Endovascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 21-Feb-2020 $26.4M 000.00 000.00 Completed Generating Revenue
4. Early Stage VC 21-Jul-2016 00.000 000.00 000.00 Completed Generating Revenue
3. Early Stage VC 30-Jun-2015 00.000 00.000 00.000 Completed Generating Revenue
2. Early Stage VC $3M Completed Generating Revenue
1. Early Stage VC (Series A) 03-May-2013 $3M $3M 00.000 Completed Generating Revenue
To view Cerus Endovascular’s complete valuation and funding history, request access »

Cerus Endovascular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 00,000 00.000000 000.0 000.0 00 000.0 0.00
Ordinary 33,789 $0.000065 $77.35 $77.35 1x $77.35 5.45%
Series A 140,388 $0.000065 $19.53 $19.53 1x $19.53 22.66%
To view Cerus Endovascular’s complete cap table history, request access »

Cerus Endovascular Executive Team (5)

Name Title Board Seat Contact Info
Stephen Griffin Ph.D Board Member, Director & President
David Jennings Chief Financial Officer & Company Secretary
Lori Adels Ph.D Chief Compliance Officer
Sam Milstein Ph.D Chairman & Director
You’re viewing 4 of 5 executive team members. Get the full list »

Cerus Endovascular Board Members (6)

Name Representing Role Since
Franklin Berger Cerus Endovascular Board Member 000 0000
John Kilcoyne Self Board Member 000 0000
Paul Brooke Self Board Member 000 0000
Sam Milstein Ph.D Cerus Endovascular Chairman & Director 000 0000
Stephen Griffin Ph.D Cerus Endovascular Board Member, Director & President 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Cerus Endovascular Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cerus Endovascular Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Andover Ventures Venture Capital Minority 000 0000 000000 0
Johnston Associates Venture Capital Minority 000 0000 000000 0
Epiphany Capital Venture Capital Minority 000 0000 000000 0
Mid Atlantic Bio Angels Angel Group Minority 000 0000 000000 0
Spark Impact Corporate Venture Capital Minority 000 0000 000000 0
To view Cerus Endovascular’s complete investors history, request access »